Terms ending in 2040
Every in-force patent on AbbVie Inc.'s record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US D1,065,814 | Carrying Pack for Medical Device In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US D1,066,015 | Container Cap In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 10,851,073 | Protein Tyrosine Phosphatase Inhibitors and Methods of Use Thereof In force · Medium confidence | Calico Life Sciences LLC | In force | Medium confidence | |
| US D1,070,274 | Carrying Vest In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 12,715,916 | Anti-Hemojuvelin (HJV) Antibodies for Treating Myelofibrosis In force · Medium confidence | AbbVie Deutschland GmbH & Co. KG | In force | Medium confidence | |
| US 12,715,917 | Methods of Using Anti-Hemojuvelin (HJV) Antibodies for Treating Myelofibrosis In force · Medium confidence | AbbVie Deutschland GmbH & Co. KG | In force | Medium confidence | |
| US D1,076,063 | Infusion Pump In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 12,251,365 | Pharmaceutical Formulations for Subcutaneous Administration In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US D1,082,224 | Carrying Vest In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 11,690,845 | Methods of Administering Elagolix In force · High confidence | AbbVie Inc. | In force | High confidence | |
| 1 more term end in 2040 · Pro | |||||
10 of 11 patents shown. Soonest term end first, then patent number.
Pro members see all 11.
10 of these are in force and held by AbbVie Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.